Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Depreciation and Depletion (2016 - 2017)

Achieve Life Sciences (ACHV) has disclosed Depreciation and Depletion for 7 consecutive years, with $37000.0 as the latest value for Q2 2017.

  • Quarterly Depreciation and Depletion fell 21.28% to $37000.0 in Q2 2017 from the year-ago period, while the trailing twelve-month figure was $215000.0 through Jun 2017, down 6.93% year-over-year, with the annual reading at $27000.0 for FY2021, 15.62% down from the prior year.
  • Depreciation and Depletion for Q2 2017 was $37000.0 at Achieve Life Sciences, down from $93000.0 in the prior quarter.
  • The five-year high for Depreciation and Depletion was $93000.0 in Q1 2017, with the low at $37000.0 in Q2 2017.
  • Average Depreciation and Depletion over 5 years is $56222.2, with a median of $55500.0 recorded in 2013.
  • The sharpest move saw Depreciation and Depletion soared 133.33% in 2013, then tumbled 39.39% in 2016.
  • Achieve Life Sciences' Depreciation and Depletion stood at $65000.0 in 2013, then fell by 10.77% to $58000.0 in 2014, then rose by 13.79% to $66000.0 in 2015, then tumbled by 39.39% to $40000.0 in 2016, then decreased by 7.5% to $37000.0 in 2017.
  • Per Business Quant, the three most recent readings for ACHV's Depreciation and Depletion are $37000.0 (Q2 2017), $93000.0 (Q1 2017), and $40000.0 (Q4 2016).